Abstract
BackgroundIndividuals with head and neck squamous cell carcinoma (HNSCC) not associated with human papillomavirus (HPV) experience high rates of recurrence and poor survival. Clinical studies suggest that neoadjuvant immune checkpoint...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have